Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 15/20 | 0.61 |
| ▸ | CA1 | P00915 | 15/20 | 0.61 |
| ▸ | CA2 | P00918 | 15/20 | 0.61 |
| ▸ | CA9 | Q16790 | 15/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 12/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5739204 | 0.99 | CA12 (0.60) | CA12CA1CA2CA9CA14 | |
| Bromide SCHEMBL2586422 | 0.99 | CA12 (0.60) | CA12CA1CA2CA9CA14 | |
| Bromide SCHEMBL5743154 | 0.99 | CA12 (0.60) | CA12CA1CA2CA9CA14 | |
| Bromide SCHEMBL10716847 | 0.97 | CA12 (0.57) | CA12CA1CA2CA9CA14 | |
| Hydrochloric Acid SCHEMBL5741360 | 0.86 | LMNA (0.50) | CA12CA1CA2CA9CA14 | |
| SCHEMBL13163929 | 0.86 | CA12 (0.67) | CA12CA1CA2CA9CA14 | |
| SCHEMBL13480225 | 0.86 | CA12 (0.67) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7151688 | 0.86 | CA12 (0.67) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7151935 | 0.86 | CA12 (0.67) | CA12CA1CA2CA9CA14 | |
| SCHEMBL3267262 | 0.86 | CA12 (0.67) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020137672-A1 | Radiolabeled annexins | KASINA SUDHAKAR (US) | 2002-09-26 | — | — | US | disclosed |
| US-6416738-B1 | ADMINISTERING TO A RECIPIENT A FIRST CONJUGATE COMPRISING A TARGETING MOIETY AND A MEMBER OF A LIGAND/ANTI-LIGAND BINDING PAIR, THEREAFTER ADMINISTERING TO THE RECIPIENT A CLEARING AGENT, ADMINISTERING SECOND CONJUGATE | NEORX CORPORATION | 2002-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137672-A1 | Radiolabeled annexins | ANXA11, ANXA1, ANXA3 | CA12 1214/4885CA1 1557/4885CA2 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.